- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
International Journal of Hypertension
Volume 2013 (2013), Article ID 513047, 6 pages
AT2 Receptor-Interacting Proteins ATIPs in the Brain
1Inserm U1016, Paris 75014, France
2CNRS UMR 8104, Paris 75014, France
3Institut Cochin, Université Paris Descartes, 22 Rue Méchain, 75014 Paris, France
4MUTABILIS S.A., 93230 Romainville, France
5J.C. Self Research Institute of Human Genetics, Greenwood Genetic Center, Greenwood, SC 29646, USA
6Caris Life Sciences, Phoenix, AZ 85040, USA
Received 29 November 2012; Accepted 22 December 2012
Academic Editor: Patrick Vanderheyden
Copyright © 2013 Sylvie Rodrigues-Ferreira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- C. Llorens-Cortes and F. A. Mendelsohn, “Organisation and functional role of the brain angiotensin system,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 3, supplement 1, pp. S39–S48, 2002.
- M. I. Phillips and E. M. De Oliveira, “Brain renin angiotensin in disease,” Journal of Molecular Medicine, vol. 86, no. 6, pp. 715–722, 2008.
- A. E. Cuadra, Z. Shan, C. Sumners, and M. K. Raizada, “A current view of brain renin-angiotensin system: is the (pro)renin receptor the missing link?” Pharmacology and Therapeutics, vol. 125, no. 1, pp. 27–38, 2010.
- A. G. Dupont and S. Brouwers, “Brain angiotensin peptides regulate sympathetic tone and blood pressure,” Journal of Hypertension, vol. 28, no. 8, pp. 1599–1610, 2010.
- J. W. Wright and J. W. Harding, “Brain renin-angiotensin-A new look at an old system,” Progress in Neurobiology, vol. 95, no. 1, pp. 49–67, 2011.
- M. Horiuchi, J. Iwanami, and M. Mogi, “Regulation of angiotensin II receptors beyond the classical pathway,” Clinical Science, vol. 123, no. 4, pp. 193–203, 2012.
- S. Higuchi, H. Ohtsu, H. Suzuki, H. Shirai, G. D. Frank, and S. Eguchi, “Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology,” Clinical Science, vol. 112, no. 7-8, pp. 417–428, 2007.
- S. Nouet and C. Nahmias, “Signal transduction from the angiotensin II AT2 receptor,” Trends in Endocrinology and Metabolism, vol. 11, no. 1, pp. 1–6, 2000.
- M. Mogi, M. Iwai, and M. Horiuchi, “Emerging concepts of regulation of angiotensin II receptors: new players and targets for traditional receptors,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 12, pp. 2532–2539, 2007.
- E. R. Porrello, L. M. Delbridge, and W. G. Thomas, “The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor,” Frontiers in Bioscience, vol. 14, no. 3, pp. 958–972, 2009.
- M. Mogi, M. Iwai, and M. Horiuchi, “New insights into the regulation of angiotensin receptors,” Current Opinion in Nephrology and Hypertension, vol. 18, no. 2, pp. 138–143, 2009.
- S. Rodrigues-Ferreira and C. Nahmias, “An ATIPical family of angiotensin II AT2 receptor-interacting proteins,” Trends in Endocrinology and Metabolism, vol. 21, no. 11, pp. 684–690, 2010.
- T. Senbonmatsu, T. Saito, E. J. Landon et al., “A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy,” EMBO Journal, vol. 22, no. 24, pp. 6471–6482, 2003.
- S. Nouet, N. Amzallag, J. M. Li et al., “Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP,” Journal of Biological Chemistry, vol. 279, no. 28, pp. 28989–28997, 2004.
- C. J. Wruck, H. Funke-Kaiser, T. Pufe et al., “Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 1, pp. 57–64, 2005.
- M. Di Benedetto, I. Bièche, F. Deshayes et al., “Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP,” Gene, vol. 380, no. 2, pp. 127–136, 2006.
- S. Shanmugam and K. Sandberg, “Ontogeny of angiotensin II receptors,” Cell Biology International, vol. 20, no. 3, pp. 169–176, 1996.
- A. M. Nuyt, Z. Lenkei, M. Palkovits, P. Corvol, and C. Llorens-Cortes, “Ontogeny of angiotensin II type 2 receptor mRNA expression in fetal and neonatal rat brain,” Journal of Comparative Neurology, vol. 407, no. 2, pp. 193–206, 1999.
- Z. Lenkei, M. Palkovits, P. Corvol, and C. Llorens-Cortès, “Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review,” Frontiers in Neuroendocrinology, vol. 18, no. 4, pp. 383–439, 1997.
- A. M. Allen, D. P. MacGregor, M. J. McKinley, and F. A. Mendelsohn, “Angiotensin II receptors in the human brain,” Regulatory Peptides, vol. 79, no. 1, pp. 1–7, 1999.
- S. Meffert, M. Stoll, U. M. Steckelings, S. P. Bottari, and T. Unger, “The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells,” Molecular and Cellular Endocrinology, vol. 122, no. 1, pp. 59–67, 1996.
- L. Laflamme, M. De Gasparo, J. M. Gallo, M. D. Payet, and N. Gallo-Payet, “Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors,” Journal of Biological Chemistry, vol. 271, no. 37, pp. 22729–22735, 1996.
- F. Côté, T. H. Do, L. Laflamme, J. M. Gallo, and N. Gallo-Payet, “Activation of the AT2 receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum,” Journal of Biological Chemistry, vol. 274, no. 44, pp. 31686–31692, 1999.
- L. Gendron, M. D. Payet, and N. Gallo-Payet, “The angiotensin type 2 receptor of angiotensin II and neuronal differentiation: from observations to mechanisms,” Journal of Molecular Endocrinology, vol. 31, no. 3, pp. 359–372, 2003.
- M. O. Guimond, C. Wallinder, M. Alterman, A. Hallberg, and N. Gallo-Payet, “Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT(2)) receptor. Effects on neurite outgrowth in NG108-15 cells,” European Journal of Pharmacology, vol. 699, no. 1–3, pp. 160–171, 2012.
- B. Maul, O. von Bohlen und Halbach, A. Becker et al., “Impaired spatial memory and altered dendritic spine morphology in angiotensin II type 2 receptor-deficient mice,” Journal of Molecular Medicine, vol. 86, no. 5, pp. 563–571, 2008.
- U. M. Steckelings, F. Rompe, E. Kaschina et al., “The past, present and future of angiotensin II type 2 receptor stimulation,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 11, no. 1, pp. 67–73, 2010.
- J. Li, J. Culman, H. Hörtnagl et al., “Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury,” The FASEB Journal, vol. 19, no. 6, pp. 617–619, 2005.
- N. Hobara, M. Goda, N. Yoshida et al., “Angiotensin II type 2 receptors facilitate reinnervation of phenol-lesioned vascular calcitonin gene-related peptide-containing nerves in rat mesenteric arteries,” Neuroscience, vol. 150, no. 3, pp. 730–741, 2007.
- M. Horiuchi, M. Mogi, and M. Iwai, “The angiotensin II type 2 receptor in the brain,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 11, no. 1, pp. 1–6, 2010.
- R. Lucius, S. Gallinat, P. Rosenstiel, T. Herdegen, J. Sievers, and T. Unger, “The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats,” Journal of Experimental Medicine, vol. 188, no. 4, pp. 661–670, 1998.
- K. Reinecke, R. Lucius, A. Reinecke, U. Rickert, T. Herdegen, and T. Unger, “Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kappaB.,” The FASEB Journal, vol. 17, no. 14, pp. 2094–2096, 2003.
- P. Namsolleck, F. Boato, K. Schwengel et al., “AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression,” Neurobiology of Disease. In press.
- J. M. Li, M. Mogi, K. Tsukuda et al., “Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1,” Molecular Endocrinology, vol. 21, no. 2, pp. 499–511, 2007.
- B. Plouffe, M. O. Guimond, H. Beaudry, and N. Gallo-Payet, “Role of tyrosine kinase receptors in angiotensin II AT2 receptor signaling: involvement in neurite outgrowth and in p42/p44mapk activation in NG108-15 cells,” Endocrinology, vol. 147, no. 10, pp. 4646–4654, 2006.
- M. O. Guimond, C. Roberge, and N. Gallo-Payet, “Fyn is involved in angiotensin II type 2 receptor-induced neurite outgrowth, but not in p42/p44mapk in NG108-15 cells,” Molecular and Cellular Neuroscience, vol. 45, no. 3, pp. 201–212, 2010.
- K. Bedecs, N. Elbaz, M. Sutren et al., “Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase,” Biochemical Journal, vol. 325, no. 2, pp. 449–454, 1997.
- N. Elbaz, K. Bedecs, M. Masson, M. Sutren, A. D. Strosberg, and C. Nahmias, “Functional trans-inactivation of insulin receptor kinase by growth-inhibitory angiotensin II AT2 receptor,” Molecular Endocrinology, vol. 14, no. 6, pp. 795–804, 2000.
- U. Stroth, S. Meffert, S. Gallinat, and T. Unger, “Angiotensin II and NGF differentially influence microtubule proteins in PC12W cells: role of the AT2 receptor,” Molecular Brain Research, vol. 53, no. 1-2, pp. 187–195, 1998.
- P. Kilian, S. Campbell, L. Bilodeau et al., “Angiotensin II type 2 receptor stimulation increases the rate of NG108-15 cell migration via actin depolymerization,” Endocrinology, vol. 149, no. 6, pp. 2923–2933, 2008.
- C. A. McCarthy, A. Vinh, J. K. Callaway, and R. E. Widdop, “Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke,” Stroke, vol. 40, no. 4, pp. 1482–1489, 2009.
- P. Gelosa, A. Pignieri, L. Fändriks et al., “Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage,” Journal of Hypertension, vol. 27, no. 12, pp. 2444–2451, 2009.
- N. Gallo-Payet, M. O. Guimond, L. Bilodeau, C. Wallinder, M. Alterman, and A. Hallberg, “Angiotensin II, a neuropeptide at the frontier between endocrinology and neuroscience: is there a link between the angiotensin II Type 2 receptor and Alzheimer's disease?” Frontiers in Endocrinology, vol. 2, p. 17, 2011.
- F. Jing, M. Mogi, A. Sakata et al., “Direct stimulation of angiotensin II type 2 receptor enhances spatial memory,” Journal of Cerebral Blood Flow & Metabolism, vol. 32, no. 2, pp. 248–255, 2012.
- U. M. Steckelings, L. Paulis, P. Namsolleck, and T. Unger, “AT2 receptor agonists: hypertension and beyond,” Current Opinion in Nephrology & Hypertension, vol. 21, no. 2, pp. 142–146, 2012.
- V. S. Vervoort, M. A. Beachem, P. S. Edwards et al., “AGTR2 mutations in X-linked mental retardation,” Science, vol. 296, no. 5577, pp. 2401–2403, 2002.
- T. Ylisaukko-oja, K. Rehnström, R. Vanhala, C. Tengström, J. Lähdetie, and I. Järvelä, “Identification of two AGTR2 mutations in male patients with non-syndromic mental retardation,” Human Genetics, vol. 114, no. 2, pp. 211–213, 2004.
- E. Takeshita, E. Nakagawa, K. Nakatani, M. Sasaki, and Y. Goto, “Novel AGTR2 missense mutation in a Japanese boy with severe mental retardation, pervasive developmental disorder, and epilepsy,” Brain and Development, vol. 34, no. 9, pp. 776–779, 2012.
- T. Bienvenu, K. Poirier, H. Van Esch et al., “Rare polymorphic variants of the AGTR2 gene in boys with non-specific mental retardation,” Journal of Medical Genetics, vol. 40, no. 5, pp. 357–359, 2003.
- J. Erdmann, S. Dähmlow, M. Guse et al., “The assertion that a G21V mutation in AGTR2 causes mental retardation is not supported by other studies (multiple letters),” Human Genetics, vol. 114, no. 4, pp. 396–397, 2004.
- D. Huang, W. Sun, and C. M. Strom, “Sequence variations in AGTR2 are unlikely to be associated with x-linked mental retardation,” American Journal of Medical Genetics, vol. 139, no. 3, pp. 243–244, 2005.
- V. S. Vervoort, G. Guzauskas, J. Archie, C. E. Schwartz, R. E. Stevenson, and A. K. Srivastava, “AGTR2 in brain development and function,” American Journal of Medical Genetics, vol. 140, no. 5, pp. 419–420, 2006.
- K. Seidel, S. Kirsch, K. Lucht et al., “The promyelocytic leukemia zinc finger (PLZF) protein exerts neuroprotective effects in neuronal cells and is dysregulated in experimental stroke,” Brain Pathology, vol. 21, no. 1, pp. 31–43, 2011.
- Y. Wan, C. Wallinder, B. Plouffe et al., “Design, synthesis, and biological evaluation, of the first selective nonpeptide AT2 receptor agonist,” Journal of Medicinal Chemistry, vol. 47, no. 24, pp. 5995–6008, 2004.
- J. Georgsson, C. Sköld, M. Botros et al., “Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor,” Journal of Medicinal Chemistry, vol. 50, no. 7, pp. 1711–1715, 2007.
- U. M. Steckelings, M. Larhed, A. Hallberg et al., “Non-peptide AT2-receptor agonists,” Current Opinion in Pharmacology, vol. 11, no. 2, pp. 187–192, 2011.
- J. Yu, X. Liu, H. Ye, and X. Zhou, “Genomic characterization of the human mitochondrial tumor suppressor gene 1 (MTUS1): 5' cloning and preliminary analysis of the multiple gene promoters,” BMC Research Notes, vol. 2, p. 109, 2009.
- S. Seibold, C. Rudroff, M. Weber, J. Galle, C. Wanner, and M. Marx, “Identification of a new tumor suppressor gene located at chromosome 8p21.3-22.,” The FASEB Journal, vol. 17, no. 9, pp. 1180–1182, 2003.
- S. Rodrigues-Ferreira, A. Di Tommaso, A. Dimitrov et al., “8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis,” PLoS ONE, vol. 4, no. 10, Article ID e7239, 2009.
- A. Molina, S. Rodrigues-Ferreira, A. Di Tommaso, and C. Nahmias, “[ATIP, a novel superfamily of microtubule-associated proteins].,” Médecine Sciences, vol. 27, no. 3, pp. 244–246, 2011.
- C. C. Hoogenraad and F. Bradke, “Control of neuronal polarity and plasticity-a renaissance for microtubules?” Trends in Cell Biology, vol. 19, no. 12, pp. 669–676, 2009.
- F. E. Poulain and A. Sobel, “The microtubule network and neuronal morphogenesis: dynamic and coordinated orchestration through multiple players,” Molecular and Cellular Neuroscience, vol. 43, no. 1, pp. 15–32, 2010.
- K. Iqbal, F. Liu, C. X. Gong, and I. Grundke-Iqbal, “Tau in Alzheimer disease and related tauopathies,” Current Alzheimer Research, vol. 7, no. 8, pp. 656–664, 2010.
- L. M. Ittner and J. Götz, “Amyloid-β and tau-a toxic pas de deux in Alzheimer's disease,” Nature Reviews Neuroscience, vol. 12, no. 2, pp. 65–72, 2011.
- S. AbdAlla, H. Lother, A. El Missiry et al., “Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease,” Journal of Biological Chemistry, vol. 284, no. 10, pp. 6554–6565, 2009.